ThZeal - The Zeal

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lucas Bruce

(Last)

(First)

(Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.,

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA

33607

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/17/2025

3. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	114,592⁽¹⁾	D
Common Stock	2,475,000⁽¹⁾	I	By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
Common Stock	39,875,000⁽¹⁾	I	By IIM Holdings II, LLC⁽²⁾
Common Stock	114,592⁽¹⁾	I	By spouse⁽³⁾
Common Stock	1,650,000⁽¹⁾	I	By spouse⁽⁴⁾
Common Stock	1,925,000⁽¹⁾	I	By spouse⁽⁵⁾
Common Stock	1,925,000⁽¹⁾	I	By spouse⁽⁶⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	435,407⁽⁷⁾	⁽⁷⁾	D
Stock Option (right to buy)	⁽⁸⁾	10/07/2031	Common Stock	1,650,000⁽⁹⁾	$0.01⁽⁹⁾	D
Stock Option (right to buy)	⁽¹⁰⁾	10/07/2031	Common Stock	1,925,000⁽⁹⁾	$0.01⁽⁹⁾	D
Stock Option (right to buy)	⁽¹¹⁾	02/24/2032	Common Stock	550,000⁽⁹⁾	$0.79⁽⁹⁾	D
Stock Option (right to buy)	⁽¹²⁾	07/12/2033	Common Stock	2,750,000⁽⁹⁾	$1.38⁽⁹⁾	D
Series A Preferred Stock	⁽¹³⁾	⁽¹³⁾	Common Stock	929,390⁽¹³⁾	⁽¹³⁾	D
Series A Preferred Stock	⁽¹³⁾	⁽¹³⁾	Common Stock	100,837⁽¹³⁾	⁽¹³⁾	I	By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
Restricted Stock Units	⁽¹⁴⁾	⁽¹⁴⁾	Common Stock	435,407⁽¹⁴⁾	⁽¹⁴⁾	I	By spouse⁽¹⁵⁾
Stock Option (right to buy)	⁽¹⁶⁾	10/07/2031	Common Stock	330,000⁽⁹⁾	$0.01⁽⁹⁾	I	By spouse⁽¹⁵⁾
Stock Option (right to buy)	⁽¹⁷⁾	02/24/2032	Common Stock	275,000⁽⁹⁾	$0.79⁽⁹⁾	I	By spouse⁽¹⁵⁾
Stock Option (right to buy)	⁽¹⁸⁾	07/12/2033	Common Stock	550,000⁽⁹⁾	$1.38⁽⁹⁾	I	By spouse⁽¹⁵⁾

Explanation of Responses:

1. The number of shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

2. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

3. Represent shares of common stock beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

4. Represent shares of common stock beneficially owned by the reporting person's spouse through Securus Risk Management LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

5. Represent shares of common stock beneficially owned by the reporting person's spouse through Emma Cloonen Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

6. Represent shares of common stock beneficially owned by the reporting person's spouse through Ava Cloonen Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

7. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the reporting person's continued employment or service through each applicable vesting date. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

8. Include 1,512,500 shares underlying the portion of the option that is vested and exercisable. The remaining portion of the option vests in equal monthly installments through September 13, 2025, subject to the reporting person's continued employment or service through each applicable vesting date.

9. The number of shares of common stock underlying stock options and the applicable exercise price give effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

10. Represent vested portion of the option that vests upon the achievement of the applicable performance goals.

11. The option vested on December 25, 2023 upon the achievement of the applicable performance goals.

12. Represent vested portion of the option that vests upon the achievement of the applicable performance goals.

13. The Series A Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. All Series A Preferred Stock will be automatically converted into shares of common stock upon the closing of the issuer's initial public offering. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

14. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the recipient's continued employment or service through each applicable vesting date. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

15. Represent securities beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

16. The option vests 25% on September 13, 2022 and in equal monthly installments thereafter ending on September 13, 2025, subject to the reporting person's continued employment or service through each applicable vesting date.

17. The option vested on December 25, 2023 upon the achievement of applicable performance goals.

18. Represent vested portion of the option that vests upon the achievement of applicable performance goals.

	/s/ Jesse Schalk, Attorney-in-Fact for Bruce Lucas	06/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.